Cosmos Health (NASDAQ:COSM) Issues Quarterly Earnings Results

Cosmos Health (NASDAQ:COSM) announced its quarterly earnings data on Wednesday. The company reported ($0.08) EPS for the quarter, Zacks reports. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%.

Cosmos Health Stock Down 0.2 %

NASDAQ COSM traded down $0.00 during trading hours on Wednesday, reaching $0.35. 327,269 shares of the company traded hands, compared to its average volume of 407,706. The company has a 50 day moving average of $0.50 and a two-hundred day moving average of $0.65. Cosmos Health has a 12 month low of $0.31 and a 12 month high of $1.58. The stock has a market capitalization of $8.07 million, a PE ratio of -0.14 and a beta of 5.50. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08.

Insider Activity

In related news, CEO Grigorios Siokas purchased 29,158 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $0.86 per share, for a total transaction of $25,075.88. Following the acquisition, the chief executive officer now directly owns 4,164,789 shares in the company, valued at approximately $3,581,718.54. The trade was a 0.71 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders bought 606,340 shares of company stock valued at $352,328. 15.61% of the stock is currently owned by company insiders.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.